Frontiers in medicine · 2025
Global and Chinese trends in acute myeloid leukemia burden (1990-2021): a comprehensive analysis based on the GBD study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lu Xiaojing, Peng Xin, Zhang Yunxiang, Zhu Hongming, Zheng Yu, Sun Yue, Ji Heyu, Li Junmin, Jin Haijiao, Li Xiaoyang
Аннотация
BACKGROUND: Acute myeloid leukemia (AML) poses a significant global health burden. This study evaluates long-term trends in AML burden from 1990 to 2021, focusing on global and Chinese patterns using Global Burden of Disease (GBD) data.
METHODS: We extracted AML-related mortality, incidence, prevalence, and disability-adjusted life years (DALYs) from the GBD 1990-2021 dataset. Age-standardized rates (ASRs) were analyzed using Joinpoint regression to calculate annual percentage change (APC) and average APC (AAPC). Contributions of smoking, high body mass index (BMI), and occupational exposures were also evaluated.
RESULTS: Globally, AML deaths rose by 73.8%, with a 17.45% increase in ASMR. Conversely, China's ASMR declined by 14.76%. DALYs showed a global AAPC of -0.83%, with a sharper decline in China (-2.40%). Males and older adults (>65 years) bore a disproportionate burden. Smoking remained the top risk factor, while high BMI showed the fastest growth in attributable burden.
CONCLUSION: While AML's absolute burden is increasing worldwide, age-adjusted metrics are stabilizing or declining in China, likely due to healthcare improvements. Targeted prevention, risk control, and geriatric-oriented AML strategies are urgently needed.
METHODS: We extracted AML-related mortality, incidence, prevalence, and disability-adjusted life years (DALYs) from the GBD 1990-2021 dataset. Age-standardized rates (ASRs) were analyzed using Joinpoint regression to calculate annual percentage change (APC) and average APC (AAPC). Contributions of smoking, high body mass index (BMI), and occupational exposures were also evaluated.
RESULTS: Globally, AML deaths rose by 73.8%, with a 17.45% increase in ASMR. Conversely, China's ASMR declined by 14.76%. DALYs showed a global AAPC of -0.83%, with a sharper decline in China (-2.40%). Males and older adults (>65 years) bore a disproportionate burden. Smoking remained the top risk factor, while high BMI showed the fastest growth in attributable burden.
CONCLUSION: While AML's absolute burden is increasing worldwide, age-adjusted metrics are stabilizing or declining in China, likely due to healthcare improvements. Targeted prevention, risk control, and geriatric-oriented AML strategies are urgently needed.